iShares Genomics Immunology and Healthcare ETF (NYSEARCA:IDNA – Get Free Report)’s stock price rose 1% on Thursday . The stock traded as high as $24.53 and last traded at $24.42. Approximately 97,392 shares changed hands during trading, an increase of 190% from the average daily volume of 33,605 shares. The stock had previously closed at $24.18.
iShares Genomics Immunology and Healthcare ETF Trading Up 0.6 %
The stock has a fifty day simple moving average of $24.51 and a 200-day simple moving average of $23.89. The stock has a market cap of $143.68 million, a price-to-earnings ratio of 2.29 and a beta of 1.14.
About iShares Genomics Immunology and Healthcare ETF
The iShares Genomics Immunology and Healthcare ETF (IDNA) is an exchange-traded fund that mostly invests in stocks based on a particular theme. The fund tracks a market-cap-selected and -weighted index of global stocks involved in genomics, immunology, and bioengineering. IDNA was launched on Jun 11, 2019 and is managed by BlackRock.
Recommended Stories
- Five stocks we like better than iShares Genomics Immunology and Healthcare ETF
- ESG Stocks, What Investors Should Know
- CarMax’s Impressive Rally: What Investors Should Watch Next
- What Are Dividends? Buy the Best Dividend Stocks
- MarketBeat Week in Review – 9/23 – 9/27
- With Risk Tolerance, One Size Does Not Fit All
- Wake Up to This Biotech Stock That Still Has Big Potential Upside
Receive News & Ratings for iShares Genomics Immunology and Healthcare ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Genomics Immunology and Healthcare ETF and related companies with MarketBeat.com's FREE daily email newsletter.
